US medical nanotechnology forum set for mid-October
This article was originally published in Clinica
Executive Summary
The US FDA will hold a public meeting this fall to help it decide how to regulate products containing nanotechnology materials. The agency said it is interested in learning about the kinds of new nanotechnology materials under development, and whether the agency can help eliminate some of the scientific hurdles that may be inhibiting the use of nanotechnology in medical product development.